Pharma future looking up? Maybe

Posted 23 February 2026 PM

The first quarter of 2026 has brought a sliver of optimism to industry with the latest pharma sentiment index climbing 12 points - though not enough to quash overwhelming concern about the current state of the sector.

The Biopharma Sentiment Index (BPSI) headline score has jumped from a 'deeply pessimistic' 78 in Q4 2025 to 90. But the good news is tempered by the fact it still falls well short of the 'neutral' baseline of 100 points.

To see the whole article please log in.

Log in with your member email for full access.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Email

Retype password

Not a member? Sign up here